Evaluation of mental and emotional state of patients with polycystic ovary syndrome on the background of hormonal contraception
Goal. The study of changes in mental and emotional state in patients with polycystic ovarian syndrome before you start taking a hormonal contraceptive containing estradiol valerate (E2V) in combination with dienogest (DNG) in dynamic mode and after 12 months against a background of continued adminis...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IP Berlin A.V.
2016-08-01
|
| Series: | Гинекология |
| Subjects: | |
| Online Access: | https://gynecology.orscience.ru/2079-5831/article/viewFile/28556/pdf |
| _version_ | 1811283920813031424 |
|---|---|
| author | T Iu Pestrikova E A Iurasova E L Sukhonosova |
| author_facet | T Iu Pestrikova E A Iurasova E L Sukhonosova |
| author_sort | T Iu Pestrikova |
| collection | DOAJ |
| description | Goal. The study of changes in mental and emotional state in patients with polycystic ovarian syndrome before you start taking a hormonal contraceptive containing estradiol valerate (E2V) in combination with dienogest (DNG) in dynamic mode and after 12 months against a background of continued administration. Materials and methods. The study included 36 patients in need of contraception (aged 22 to 31 years), with the presence of symptoms of hyperandrogenism and menstrual irregularities. All patients completed self-assessment questionnaires for mental and emotional state before the reception and at 12 months in patients receiving hormonal contraceptive. Results. Hormonal contraceptive (E2V in combination with DTG) used in a continuous dynamic mode, has a positive therapeutic effect against clinical manifestations of hyperandrogenism and reproductive status of patients with PCOS. The therapeutic effect in combination with E2V dienogest was to authentic decrease in severity of symptoms of hyperandrogenism (acne, fat skin). In addition, in patients receiving hormonal contraceptive it noted improvements in mental and emotional state of patients with polycystic ovary syndrome, which is caused by a decrease in symptoms of hyperandrogenism, and the normalization of body weight (by diet). |
| first_indexed | 2024-04-13T02:19:53Z |
| format | Article |
| id | doaj.art-12f0f3e813eb4b369c0544622d997b82 |
| institution | Directory Open Access Journal |
| issn | 2079-5696 2079-5831 |
| language | Russian |
| last_indexed | 2024-04-13T02:19:53Z |
| publishDate | 2016-08-01 |
| publisher | IP Berlin A.V. |
| record_format | Article |
| series | Гинекология |
| spelling | doaj.art-12f0f3e813eb4b369c0544622d997b822022-12-22T03:07:00ZrusIP Berlin A.V.Гинекология2079-56962079-58312016-08-01184495325686Evaluation of mental and emotional state of patients with polycystic ovary syndrome on the background of hormonal contraceptionT Iu Pestrikova0E A Iurasova1E L Sukhonosova2Far Eastern State Medical University of the Ministry of Health of the Russian FederationFar Eastern State Medical University of the Ministry of Health of the Russian FederationFar Eastern State Medical University of the Ministry of Health of the Russian FederationGoal. The study of changes in mental and emotional state in patients with polycystic ovarian syndrome before you start taking a hormonal contraceptive containing estradiol valerate (E2V) in combination with dienogest (DNG) in dynamic mode and after 12 months against a background of continued administration. Materials and methods. The study included 36 patients in need of contraception (aged 22 to 31 years), with the presence of symptoms of hyperandrogenism and menstrual irregularities. All patients completed self-assessment questionnaires for mental and emotional state before the reception and at 12 months in patients receiving hormonal contraceptive. Results. Hormonal contraceptive (E2V in combination with DTG) used in a continuous dynamic mode, has a positive therapeutic effect against clinical manifestations of hyperandrogenism and reproductive status of patients with PCOS. The therapeutic effect in combination with E2V dienogest was to authentic decrease in severity of symptoms of hyperandrogenism (acne, fat skin). In addition, in patients receiving hormonal contraceptive it noted improvements in mental and emotional state of patients with polycystic ovary syndrome, which is caused by a decrease in symptoms of hyperandrogenism, and the normalization of body weight (by diet).https://gynecology.orscience.ru/2079-5831/article/viewFile/28556/pdfpolycystic ovary syndromehyperandrogenismestradiol valerate combined with dienogestassessment of mental and emotional state |
| spellingShingle | T Iu Pestrikova E A Iurasova E L Sukhonosova Evaluation of mental and emotional state of patients with polycystic ovary syndrome on the background of hormonal contraception Гинекология polycystic ovary syndrome hyperandrogenism estradiol valerate combined with dienogest assessment of mental and emotional state |
| title | Evaluation of mental and emotional state of patients with polycystic ovary syndrome on the background of hormonal contraception |
| title_full | Evaluation of mental and emotional state of patients with polycystic ovary syndrome on the background of hormonal contraception |
| title_fullStr | Evaluation of mental and emotional state of patients with polycystic ovary syndrome on the background of hormonal contraception |
| title_full_unstemmed | Evaluation of mental and emotional state of patients with polycystic ovary syndrome on the background of hormonal contraception |
| title_short | Evaluation of mental and emotional state of patients with polycystic ovary syndrome on the background of hormonal contraception |
| title_sort | evaluation of mental and emotional state of patients with polycystic ovary syndrome on the background of hormonal contraception |
| topic | polycystic ovary syndrome hyperandrogenism estradiol valerate combined with dienogest assessment of mental and emotional state |
| url | https://gynecology.orscience.ru/2079-5831/article/viewFile/28556/pdf |
| work_keys_str_mv | AT tiupestrikova evaluationofmentalandemotionalstateofpatientswithpolycysticovarysyndromeonthebackgroundofhormonalcontraception AT eaiurasova evaluationofmentalandemotionalstateofpatientswithpolycysticovarysyndromeonthebackgroundofhormonalcontraception AT elsukhonosova evaluationofmentalandemotionalstateofpatientswithpolycysticovarysyndromeonthebackgroundofhormonalcontraception |